Malaysia vs Switzerland: Previously treated cases tested for RR-/MDR-TB
Malaysia
43.0%
in 2024
Switzerland
48.0%
in 2024
Malaysia rank
155th
Switzerland rank
153rd
Previously treated cases tested for RR-/MDR-TB over time
- Malaysia
- Switzerland
How they compare
Switzerland currently reports 48.0% against 43.0% in Malaysia, a difference of 5.0%.
That makes Switzerland's figure about 1.1 times Malaysia's.
The two have swapped places 7 times across 13 shared years of data; in 2005 it was Malaysia ahead.
Malaysia ranks 155th and Switzerland ranks 153rd of 180 countries.
Across the 3 decades both report, Malaysia averaged higher in 2 and Switzerland in 1.
Head to head by decade
| Decade | Malaysia | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 61.0% | 39.0% | Malaysia |
| 2010s | 44.1% | 60.3% | 16.1% | Switzerland |
| 2020s | 74.2% | 36.6% | 37.6% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Malaysia or Switzerland?
- Switzerland, at 48.0% against 43.0% in Malaysia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Malaysia and Switzerland?
- 5.0%, with Switzerland ahead.
- How many years of comparable data are there for Malaysia and Switzerland?
- 13 years are reported by both, from 2005 to 2024.
- How do Malaysia and Switzerland rank globally for previously treated cases tested for rr-/mdr-tb?
- Malaysia ranks 155th and Switzerland ranks 153rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.